Prime Medicine, Inc

Prime Medicine, Inc (PRME) Price Prediction & Forecast

$3.830

+0.397 (+10.37%)At close

Price Predictions

1-Day Price Prediction
+0.70%
1-Week Prediction
-2.13%
1-Month Prediction
—
2026 Prediction
—
2030 Prediction
—

Open in app to unlock longer-horizon forecasts.

Loading chart…

PRME Prediction & Forecast by Similar Chart Analysis

Alphio's PRME stock price prediction model matches the current Prime Medicine, Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.86 (+0.70%). The 1-week path is $3.75 (-2.13%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Should I Buy Prime Medicine, Inc Stock?

Prime Medicine Inc is not a strong buy at the moment, as it is currently priced at $3.47, down 13.03% over the last 5 days, and has a negative EPS of -0.24. While analysts have set a price target of $7 to $8, indicating potential upside, the recent performance and ongoing losses present significant risks.

PRME stock price ended at $3.83 on Monday, after rising +10.37%

Prime Medicine, Inc (PRME) last closed at $3.83, gaining +10.37%. These facts feed the 1-day and 1-week PRME price prediction above.

Forecast Drivers

Prime Medicine, Inc (PRME) forecast drivers combine similar chart patterns, seasonality, and moving averages.

Similar patterns

Positive

Bullish

Seasonality

Positive

Bullish

SMA 20

Positive

Bullish

SMA 200

Positive

Bullish

Similar Chart Patterns

Stocks whose recent price path most closely matches PRME, ranked by similarity.

Seasonality analysis for PRME

Historically the probability of a positive October return for PRME is 50.00%. January offers the highest probability of a positive month at 52.46%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading